发明名称 |
Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases |
摘要 |
To provide a therapeutic agent and a diagnostic agent for mitochondrial dysfunction brain diseases including cerebral infarction as a representative.;A therapeutic agent for a mitochondrial dysfunction brain disease, which comprises (A) δ-aminolevulinic acid represented by the formula (1), a derivative thereof, or a salt thereof and (B) an iron compound in combination.
R2R1NCH2COCH2CH2COR3 (1)
wherein R1 and R2 each independently represents a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; and R3 represents a hydroxy group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group. |
申请公布号 |
US8927532(B2) |
申请公布日期 |
2015.01.06 |
申请号 |
US201213613565 |
申请日期 |
2012.09.13 |
申请人 |
SBI Pharmaceuticals Co., Ltd. |
发明人 |
Kuroiwa Toshihiko;Kajimoto Yoshinaga;Masubuchi Takahiro;Ishizuka Masahiro;Tanaka Tohru |
分类号 |
A61K31/555;A61K31/195;A61K31/295;A61K31/197;A61K31/198;A61K33/26;A61K45/06;A61K49/00 |
主分类号 |
A61K31/555 |
代理机构 |
Sughrue Mion, PLLC |
代理人 |
Sughrue Mion, PLLC |
主权项 |
1. A method for treating a mitochondrial dysfunction brain disease selected from the group consisting of Parkinson's Disease, Alzheimer's Disease, atherothrombotic cerebral infarction, cerebral ischemia at surgery and intravascular surgery, comprising administering to a subject, an effective amount of a therapeutic agent which comprises:
(A) a δ-aminolevulinic acid represented by the formula (1), a derivative thereof, or a salt thereof:
R2R1NCH2COCH2CH2COR3 (1) wherein R1 and R2 each independently represents a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; and R3 represents a hydroxy group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group, and (B) an iron compound. |
地址 |
Tokyo JP |